Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI)
Authors not listed
IRCCS Centro San Giovanni di Dio Fatebenefratelli · 2026
Abstract
Population ageing is one of the main factors responsible for the global increase in the prevalence of dementia. Recent evidence suggests that modifiable risk factors, such as cardiovascular disease and lifestyle, may increase the risk of developing dementia and contribute to its progression. Furthermore, the use of non-invasive plasma biomarkers enables the identification of individuals with neurodegenerative diseases, even in the prodromal stage. However, the relationship between the cumulative burden of risk factors and plasma biomarkers is still poorly understood.
The main objective of this study is to identify and estimate the risk associated with modifiable and non-modifiable predictors (risk factors) linked to the development of Alzheimer's disease (AD) and non-AD dementia, as well as biological alterations consistent with AD or non-AD, through the development of a predictive tool based on Artificial Intelligence algorithms (Machine Learning model). The study also aims to provide a range of technological tools (an app for active patient monitoring and a web platform for clinicians) that could improve risk stratification and the personalisation of care pathways.
The study is divided into two different phases. Firstly, a retrospective phase is conducted in order to construct a predictive model for the risk of dementia and biological alterations consistent with AD. Secondly, a prospective phase is performed for the validation of the predictive model.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Anonymous. (2026). Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI). <em>IRCCS Centro San Giovanni di Dio Fatebenefratelli</em>. https://clinicaltrials.gov/study/NCT07731191
Vancouver
Anonymous. Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI). IRCCS Centro San Giovanni di Dio Fatebenefratelli. 2026.
BibTeX
@misc{anon2026Develo,
title = {Development of Digital Solutions for the Prediction of the Biological Mechanisms of Alzheimer's Disease Through the Analysis of Risk Factors (PrevAI)},
author = {Anonymous},
journal = {IRCCS Centro San Giovanni di Dio Fatebenefratelli},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Public Health 2025
Open access · CC-BY
The current status, trends, and challenges of Alzheimer’s disease and other dementias in Asia (1990–2036)
Peking University First Hospital 2024
Open access · US-GOV
Blood-based Biomarkers for Early Alzheimer's Disease Screening
Frontiers in Molecular Neuroscience 2017
Open access · CC-BY
The Endoplasmic Reticulum Unfolded Protein Response in Neurodegenerative Disorders and Its Potential Therapeutic Significance
Aging advances 2026
Open access · OA
Dementia, mood disorders, and aging: Bridging new avenues of care through shared biological pathways.
Nutrients 2022
Open access · CC-BY
The Effect of Nutrition on Aging—A Systematic Review Focusing on Aging-Related Biomarkers
Ophthalmic and Physiological Optics 2020
Open access · CC-BY